Tempest Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell TPST and other ETFs, options, and stocks.About TPST
Tempest Therapeutics, Inc. is a clinical-stage oncology company advancing a diverse portfolio of small molecule product candidates containing tumor-targeted and/or immune-mediated mechanisms with the potential to treat a wide range of tumors. The company’s novel programs range from early research to later-stage investigation in a randomized global study in first-line cancer patients.
CEOStephen R. Brady
CEOStephen R. Brady
Employees25
Employees25
HeadquartersBrisbane, California
HeadquartersBrisbane, California
Founded2011
Founded2011
Employees25
Employees25
TPST Key Statistics
Market cap23.53M
Market cap23.53M
Price-Earnings ratio-0.36
Price-Earnings ratio-0.36
Dividend yield—
Dividend yield—
Average volume40.66K
Average volume40.66K
High today$6.66
High today$6.66
Low today$6.11
Low today$6.11
Open price$6.59
Open price$6.59
Volume42.88K
Volume42.88K
52 Week high$47.45
52 Week high$47.45
52 Week low$5.35
52 Week low$5.35
People also own
Based on the portfolios of people who own TPST. This list is generated using Robinhood data, and it’s not a recommendation.